Search
Search Results
##search.searchResults.foundPlural##
-
The Outcome of Six Patients with COVID-19 Infection and Multiple Myeloma. A Case Series and Literature Review COVID-19 in Multiple Myeloma patients
1001PDF: 366HTML: 207 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3575PDF: 2503HTML: 1490 -
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
3033PDF: 910HTML: 1997 -
TOXICITIES ASSOCIATED WITH CAR-T CELL THERAPIES CAR-T Cell Toxicity
2267PDF: 1621HTML: 274 -
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1556PDF: 886HTML: 984figures: 184table 1: 186table2: 183table3: 186 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7646PDF: 2433HTML: 1739Table 1.: 212Table 2.: 221Table 3.: 205Table 4.: 205 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2629PDF: 1621HTML: 2373Table1: 191 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1573PDF: 394HTML: 212 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1130PDF: 498HTML: 243 -
-
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1557PDF: 789HTML: 205 -
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1630PDF: 589HTML: 231 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1377PDF: 845HTML: 139 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2128PDF: 999HTML: 4078Cover Letter: 224Figure 1: 235Figure 2: 233Table 1: 205 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4139PDF: 1714HTML: 1026 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1414PDF: 823HTML: 3123 -
Skin Involvement in Primary Systemic Amyloidosis
1651PDF: 896HTML: 4376Figure 1. Photographs showing (a) enlarged tongue with (b) teeth marks over the lateral margin and (c, d) multiple, papular lesions over lower chest wall: 181Figure 2. Microphotograph showing pink eosinophilic homogenous material in the dermis, H&E X 20: 154Figure 3. Pink eosinophilic material showing pale orange positivity with Congo red stain: 176 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1859PDF: 722HTML: 2113Untitled: 222Untitled: 156Untitled: 176Untitled: 160Untitled: 168Untitled: 183Untitled: 189 -
CRYOGLOBULIN TEST AND CRYOGLOBULINEMIA HEPATITIS C-VIRUS RELATED
3982PDF: 1304HTML: 2271 -
THE SYSTEMIC MASTOCYTOSIS: RADIOLOGICAL POINT OF VIEW Systemic mastocytosis
1518PDF: 550HTML: 730 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1257PDF: 476HTML: 18609Figure 1: 174Figure 2: 154Figure 3: 171Figure 4: 209Figure 5: 181 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2213PDF: 2049HTML: 195 -
COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon in a patient with monoclonal gammopathy of undetermined significance COVID-19-associated cold agglutinin syndrome and hemophagocytic phenomenon
844PDF: 827HTML: 130 -
Cytomorphology of Chimeric Antigen Receptor T-Cells (CAR-T)
1230PDF: 528HTML: 226 -
Complex and Multifaceted Therapy-Related Myeloid Neoplasm Following Laryngeal Cancer Treated with Cisplatin and Radiotherapy
1192PDF: 762HTML: 1358Figure 1: 191Figure 2: 192







